Formulation and evaluation of a testosterone transdermal spray

被引:26
作者
Leichtnam, Marie-Laure
Rolland, Herve
Wuthrich, Patrick
Guy, Richard H.
机构
[1] Univ Geneva, Sch Pharmaceut Sci, CH-1211 Geneva 4, Switzerland
[2] Drug Delivery Res, Formulat Dept, Technol Serv, F-45000 Orleans, France
[3] Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England
关键词
aerosols; transdermal drug delivery; skin; formulation; passive diffusion; transport;
D O I
10.1002/jps.20641
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The long-term goal is to develop a spray formulation for transdermal testosterone delivery, and to optimize the drug's skin permeability. Testosterone transport from a series of ethanol/propylene glycol (PG)/water formulations was assessed in vitro across hairless rat skin, and the optimal composition determined. The formulation was then modified for delivery from a mechanical spray, and from an aerosol containing a high percentage of propellant. Drug transport was greatest from a saturated solution in 1:1:1 ethanol/PG/water (1.7 +/- 0.2 mu g/cm(2) . h); five spray formulations were then tested, but only 1: 1 ethanol/PG achieved a comparable flux. Increasing the % ethanol in the mixture increased evaporation rate but did not alter testosterone delivery. Formulation as an aerosol produced primarily unstable vehicles (phase separation, crystallization). Only 3:1 ethanol/PG remained stable, but no significant improvement in drug transport was observed (testosterone precipitated rapidly at the skin surface). The 1:1:1 ethanol/PG/water saturated solution suggested that some penetration enhancement was possible. Eliminating water to improve sprayability identified 1: 1 ethanol/PG as a vehicle, which might allow transient supersaturation (and improved delivery). However, this effect was not improved by using a pressurized aerosol due to instability. Finally, testosterone fluxes were 5 to 10-fold lower than those required for useful transdermal therapy. (c) 2006 Wiley-Liss, Inc.
引用
收藏
页码:1693 / 1702
页数:10
相关论文
共 30 条
[1]  
BARRY BW, 1983, DERMATOLOGICAL FORMU, P127
[2]  
Beckett AH., 1982, DERMAL TRANSDERMAL A, P154
[3]   ETHANOL WATER MUTUALLY ENHANCED TRANSDERMAL THERAPEUTIC SYSTEM .2. SKIN PERMEATION OF ETHANOL AND NITROGLYCERIN [J].
BERNER, B ;
MAZZENGA, GC ;
OTTE, JH ;
STEFFENS, RJ ;
JUANG, RH ;
EBERT, CD .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1989, 78 (05) :402-407
[4]  
CAMPBELL PS, 1987, Patent No. 4704282
[5]  
Chien YW, 1987, TRANSDERMAL CONTROLL, P1
[6]  
DAVIS J, 1993, PHARM SKIN PERMEATIO, P243
[7]   Transdermal delivery of sodium nonivamide acetate from volatile vehicles: effects of polymers [J].
Fang, JY ;
Kuo, CT ;
Huang, YB ;
Wu, PC ;
Tsai, YH .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 176 (02) :157-167
[8]   EFFECT OF VEHICLE ON THE SKIN PERMEABILITY OF DRUGS - POLYETHYLENE-GLYCOL 400-WATER AND ETHANOL-WATER BINARY SOLVENTS [J].
HATANAKA, T ;
SHIMOYAMA, M ;
SUGIBAYASHI, K ;
MORIMOTO, Y .
JOURNAL OF CONTROLLED RELEASE, 1993, 23 (03) :247-260
[9]  
HIGHUCHI T, 1979, Patent No. 4144317
[10]  
Higuchi T., 1960, J SOC COSMET CHEM, V11, P85